{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:23:05Z","timestamp":1793305385010,"version":"4.5.0"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113606","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T10:58:51Z","timestamp":1622977131000},"page":"113606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5263-3588","authenticated-orcid":false,"given":"Ojasvi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-0819","authenticated-orcid":false,"given":"Tathagata","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-8749","authenticated-orcid":false,"given":"Rohit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-6241","authenticated-orcid":false,"given":"Vikramdeep","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113606_bib1","series-title":"Livestock Infectious Diseases and Zoonoses","author":"Tomley","year":"2009"},{"key":"10.1016\/j.ejmech.2021.113606_bib2","first-page":"281","article-title":"Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections","volume":"61","author":"Deitsch","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2021.113606_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New world and old world Leishmania infections: a practical review","volume":"33","author":"Kevric","year":"2015","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ejmech.2021.113606_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0020-7519(00)00136-3","article-title":"The leishmaniases as emerging and reemerging zoonoses","volume":"30","author":"Ashford","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113606_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib7","first-page":"151","volume":"vol. 48","author":"Dantas-Torres","year":"2006"},{"key":"10.1016\/j.ejmech.2021.113606_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4269\/ajtmh.12-0690","article-title":"Cutaneous leishmaniasis \u201cchiclero\u2019s ulcer\u201d in subtropical Ecuador","volume":"89","author":"Calvopi\u00f1a","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113606_bib9","article-title":"Cutaneous leishmaniasis in subtropical Ecuador: popular perceptions, knowledge, and treatment","volume":"28","author":"Weigel","year":"1994","journal-title":"Bull. Pan Am. Health Organ."},{"key":"10.1016\/j.ejmech.2021.113606_bib10","series-title":"Cutaneous Leishmaniasis in Hamadan","author":"Nazari","year":"2012"},{"key":"10.1016\/j.ejmech.2021.113606_bib11","doi-asserted-by":"crossref","first-page":"20539","DOI":"10.2807\/1560-7917.ES2013.18.30.20539","article-title":"Epidemiological surveillance of leishmaniasis in the European Union: operational and research challenges","volume":"18","author":"Gradoni","year":"2013","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ejmech.2021.113606_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S0031182018000471","article-title":"Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region","volume":"145","author":"Karunaweera","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2021.113606_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.inhe.2009.12.005","article-title":"Increase of imported Leishmaniasis in The Netherlands: a twelve year overview (1996\u20132007)","volume":"2","author":"Herremans","year":"2010","journal-title":"Int. Health"},{"key":"10.1016\/j.ejmech.2021.113606_bib14","series-title":"Neglected Tropical Diseases in Europe: Rare Diseases and Orphan Drugs?","author":"Calleri","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113606_bib15","series-title":"Introduction of Visceral Leishmaniasis (Kala-Azar), Spatial Mapping and Modelling for Kala-Azar Disease","first-page":"1","author":"Bhunia","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113606_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dkr480","article-title":"In\u00a0vitro leishmanicidal activity of imidazole-or pyrazole-based benzo [g] phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species","volume":"67","author":"S\u00e1nchez-Moreno","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113606_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/cbdd.13124","article-title":"Ensemble-based ADME\u2013Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2","volume":"91","author":"Scala","year":"2018","journal-title":"8?CTE, Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113606_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-019-0565-1","article-title":"Impact of past and on-going changes on climate and weather on vector-borne diseases transmission: a look at the evidence","volume":"8","author":"Fouque","year":"2019","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.ejmech.2021.113606_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3945\/an.114.006361","article-title":"Undernutrition, the acute phase response to infection, and its effects on micronutrient status indicators","volume":"5","author":"Bresnahan","year":"2014","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.ejmech.2021.113606_bib20","doi-asserted-by":"crossref","first-page":"110712","DOI":"10.1016\/j.nut.2019.110712","article-title":"Nutrition, malnutrition, and leishmaniasis","volume":"73","author":"Nweze","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.ejmech.2021.113606_bib21","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1017\/S0031182000086121","article-title":"Deforestation: effects on vector-borne disease","volume":"106","author":"Walsh","year":"1993","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2021.113606_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1590\/S1678-91992006000400002","article-title":"Impact of leishmaniasis on public health","volume":"12","author":"Camargo","year":"2006","journal-title":"J.\u00a0Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib23","first-page":"32","article-title":"To evaluate the costs of prevention on incidence of Cutaneous leishmaniasis due of earthquake in Bam","volume":"6","author":"Aflatoonian","year":"2010","journal-title":"Iran. J. Epidemiol."},{"key":"10.1016\/j.ejmech.2021.113606_bib24","first-page":"2012","article-title":"Leishmaniasis and climate change\u2014case study: Argentina","author":"Salom\u00f3n","year":"2012","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib25","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3201\/eid1612.100953","article-title":"Leishmania tropica infection in golden jackals and red foxes, Israel","volume":"16","author":"Talmi-Frank","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004349","article-title":"A\u00a0historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tmaid.2014.09.007","article-title":"Leishmaniasis in travelers: a literature review","volume":"12","author":"Mansueto","year":"2014","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib28","series-title":"Tropical Disease Research: a Global Partnership, Eighth Programme Report, the First Ten Years, with Highlights of the 1985-86 Biennium","author":"Maurice","year":"1987"},{"key":"10.1016\/j.ejmech.2021.113606_bib29","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113606_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2021.113606_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ejmech.2021.113606_bib32","first-page":"309","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ejmech.2021.113606_bib33","first-page":"281","article-title":"Localized leishmaniasis of the oral mucosa: a report of three cases","volume":"12","author":"Garc\u00eda de Marcos","year":"2007","journal-title":"Med. Oral, Patol. Oral Cirug\u00eda Bucal"},{"key":"10.1016\/j.ejmech.2021.113606_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3201\/eid1303.060242","article-title":"Leishmania donovani and cutaneous leishmaniasis, Sri Lanka","volume":"13","author":"Siriwardana","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4269\/ajtmh.2005.73.74","article-title":"Risk factors for Indian kala-azar","volume":"73","author":"Ranjan","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113606_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2018.08.012","article-title":"An update on small molecule strategies targeting leishmaniasis","volume":"157","author":"Kapil","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1051\/parasite\/1990651037","article-title":"The life-cycle of Leishmania in the sandfly with special reference to the form infective to the vertebrate host","volume":"65","author":"Killick-Kendrick","year":"1990","journal-title":"Ann. Parasitol. Hum. Comp."},{"key":"10.1016\/j.ejmech.2021.113606_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fmb.14.103","article-title":"Leishmania and the macrophage: a multifaceted interaction","volume":"10","author":"Podinovskaia","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejmech.2021.113606_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113606_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: newer developments","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113606_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment\u2014a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib44","first-page":"277","article-title":"Leishmaniasis: drug resistance and natural products","volume":"22","author":"Polonio","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib45","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/molecules13030616","article-title":"Prodrugs for the treatment of neglected diseases","volume":"13","author":"Chung","year":"2008","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejmech.2021.113606_bib46","first-page":"538","article-title":"Topical treatment for cutaneous leishmaniasis","volume":"3","author":"Garnier","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2021.113606_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s004300100088","article-title":"Treatment of visceral leishmaniasis","volume":"190","author":"Sundar","year":"2001","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2021.113606_bib48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113606_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","article-title":"Leishmaniasis: current status of available drugs and new potential drug targets","volume":"5","author":"Singh","year":"2012","journal-title":"Asian Pacific J. Trop. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib50","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/AAC.37.9.1842","article-title":"Antileishmanial activity of sodium stibogluconate fractions","volume":"37","author":"Roberts","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113606_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0014-4894(88)90012-4","article-title":"Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam)","volume":"67","author":"Berman","year":"1988","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113606_bib52","first-page":"2011","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"key":"10.1016\/j.ejmech.2021.113606_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molbiopara.2015.11.003","article-title":"Thiol redox biology of trypanosomatids and potential targets for chemotherapy","volume":"206","author":"Leroux","year":"2016","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113606_bib54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinids\/7.5.625","article-title":"Pentamidine: a review","volume":"7","author":"Sands","year":"1985","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113606_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/clind\/16.3.417","article-title":"Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia","volume":"16","author":"Soto-Mancipe","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib57","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-4362.2002.01633.x","article-title":"A\u00a0Fat, Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam","volume":"41","author":"Lai A Fat","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejmech.2021.113606_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000018343","article-title":"Treatment of Old World cutaneous leishmaniasis by pentamidine isethionate","volume":"200","author":"Hellier","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.ejmech.2021.113606_bib59","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/jbm.b.34058","article-title":"\u201cClick\u201d on PLGA-PEG and hyaluronic acid: Gaining access to anti-leishmanial pentamidine bioconjugates","volume":"106","author":"Scala","year":"2018","journal-title":"J.\u00a0Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ejmech.2021.113606_bib60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J.\u00a0Global Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Saravolatz","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002329900349","article-title":"Conformational analysis of amphotericin B\u2014cholesterol channel complex","volume":"162","author":"Silberstein","year":"1998","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.ejmech.2021.113606_bib63","first-page":"175","article-title":"Drug discovery and development for neglected diseases: the DNDi model","volume":"5","author":"Chatelain","year":"2011","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2021.113606_bib64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00001432-200310000-00005","article-title":"Current treatment approaches to leishmaniasis","volume":"16","author":"Berman","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2021.113606_bib66","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0140-6736(91)91708-3","article-title":"Liposomal amphotericin B in drug-resistant visceral leishmaniasis","volume":"337","author":"Davidson","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113606_bib67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations","volume":"38","author":"Sundar","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib68","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib69","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.trstmh.2006.02.011","article-title":"Oral miltefosine for the treatment of Indian visceral leishmaniasis","volume":"100","author":"Sundar","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113606_bib70","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00001813-200011000-00006","article-title":"Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients","volume":"11","author":"Smorenburg","year":"2000","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.ejmech.2021.113606_bib71","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib72","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113606_bib73","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113606_bib74","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425255.4.9.1209","article-title":"Treatment of leishmaniasis with miltefosine: 2008 status","volume":"4","author":"Berman","year":"2008","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113606_bib75","first-page":"90","article-title":"Comparative study of the chemotherapeutic effect of paromomycin and monomycin in experimental cutaneous leischmaniasis in albino mice","volume":"29","author":"Moskalenko","year":"1966","journal-title":"Farmakologiia i toksikologiia"},{"key":"10.1016\/j.ejmech.2021.113606_bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/excr.1997.3500","article-title":"VivoInterference of paromomycin with mitochondrial activity ofLeishmania","volume":"232","author":"Maarouf","year":"1997","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib77","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"326","author":"Martinez","year":"1992","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0035-9203(81)90198-X","article-title":"Allopurinol in the treatment of visceral leishmaniasis","volume":"75","author":"Kager","year":"1981","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113606_bib79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1939-1676.1999.tb01455.x","article-title":"Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)","volume":"13","author":"Denerolle","year":"1999","journal-title":"J.\u00a0Vet. Intern. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","article-title":"Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate","volume":"24","author":"Martinez","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib81","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM198709243171307","article-title":"The use of ketoconazole as an inhibitor of steroid production","volume":"317","author":"Sonino","year":"1987","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","article-title":"Ketoconazole blocks adrenal steroid synthesis","volume":"97","author":"Pont","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2021.113606_bib83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/1120009X.1990.11739020","article-title":"Combination therapy in systemic mycosis","volume":"2","author":"Polak","year":"1990","journal-title":"J.\u00a0Chemother."},{"key":"10.1016\/j.ejmech.2021.113606_bib84","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2021.113606_bib85","article-title":"Current treatment of leishmaniasis: a review","volume":"1","author":"Monzote","year":"2009","journal-title":"Open Antimicrob. Agents J."},{"key":"10.1016\/j.ejmech.2021.113606_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2021.113606_bib87","doi-asserted-by":"crossref","first-page":"13140","DOI":"10.1021\/acs.jmedchem.0c01589","article-title":"Evaluation of the pharmacophoric role of the O\u2013O bond in synthetic antileishmanial compounds: comparison between 1, 2-dioxanes and tetrahydropyrans","volume":"63","author":"Ortalli","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182017000993","article-title":"Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art","volume":"145","author":"Charlton","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2021.113606_bib89","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1874104501105010031","article-title":"Structures, targets and recent approaches in anti-leishmanial drug discovery and development","volume":"5","author":"Seifert","year":"2011","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.ejmech.2021.113606_bib90","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s42485-020-00035-w","article-title":"Review on natural products as an alternative to contemporary anti-leishmanial therapeutics","volume":"11","author":"Raj","year":"2020","journal-title":"J.\u00a0Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2021.113606_bib91","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00829-19","article-title":"Pharmacokinetics and pharmacodynamics of the nitroimidazole DNDI-0690 in mouse models of cutaneous leishmaniasis","volume":"63","author":"Wijnant","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113606_bib92","series-title":"Drug Discovery Research","article-title":"Development of DNDI-0690: a new clinical candidate for visceral leishmaniasis, 7th International Symposium on Current Trends","author":"Thompson","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113606_bib93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1039\/9781788010177-00024","article-title":"Anti-leishmanial drug discovery: past, present and future perspectives","volume":"60","author":"Mowbray","year":"2017","journal-title":"Drug Discov. Leishmaniasis"},{"key":"10.1016\/j.ejmech.2021.113606_bib94","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acs.jmedchem.8b01218","article-title":"Identification of GSK3186899\/DDD853651 as a preclinical development candidate for the treatment of visceral leishmaniasis","volume":"62","author":"Thomas","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib95","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113606_bib96","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00001756-199805110-00004","article-title":"Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats","volume":"9","author":"Rho","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejmech.2021.113606_bib97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.parint.2007.01.004","article-title":"Leishmanicidal activity of a supercritical fluid fraction obtained from Tabernaemontana catharinensis","volume":"56","author":"Soares","year":"2007","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2021.113606_bib98","series-title":"Anti-HIV-1 Activity of the Iboga Alkaloid Congener 18-methoxycoronaridine","author":"Silva","year":"2004"},{"key":"10.1016\/j.ejmech.2021.113606_bib99","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","volume":"34","author":"Ward","year":"1987","journal-title":"Pentoxifylline, Drugs"},{"key":"10.1016\/j.ejmech.2021.113606_bib100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113606_bib101","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113606_bib102","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1590\/0037-8682-0202-2013","article-title":"Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl\/6 mice","volume":"47","author":"Santarem","year":"2014","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ejmech.2021.113606_bib103","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/AAC.42.5.1076","article-title":"Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime)","volume":"42","author":"Roberts","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113606_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0035-9203(88)90267-2","article-title":"Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate","volume":"82","author":"Chulay","year":"1988","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113606_bib105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1517\/17460441.2011.550914","article-title":"The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases","volume":"6","author":"Bongarzone","year":"2011","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113606_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/chin.199438184","article-title":"Studies on benzoquinoline derivatives: preparation and antimicrobial activity of Azo derivatives (I) of Arylthiobenzo (f) quinoline","volume":"25","author":"Bahuguna","year":"1994","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2021.113606_bib107","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2018.05.014","article-title":"Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents","volume":"154","author":"Upadhyay","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-328X(02)01158-0","article-title":"Development of Pd\u2013Cu catalyzed cross-coupling of terminal acetylenes with sp2-carbon halides","volume":"653","author":"Sonogashira","year":"2002","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib109","doi-asserted-by":"crossref","first-page":"115511","DOI":"10.1016\/j.bmc.2020.115511","article-title":"Cytotoxicity of 4-substituted quinoline derivatives: anticancer and antileishmanial potential","author":"Costa","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1570179412666150706183906","article-title":"The Povarov reaction as a versatile strategy for the preparation of 1, 2, 3, 4-tetrahydroquinoline derivatives: an overview","volume":"13","author":"Bello Forero","year":"2016","journal-title":"Curr. Org. Synth."},{"key":"10.1016\/j.ejmech.2021.113606_bib111","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0160-9327(05)80086-9","article-title":"Multicomponent reactions in organic chemistry","volume":"18","author":"Ugi","year":"1994","journal-title":"Endeavour"},{"key":"10.1016\/j.ejmech.2021.113606_bib112","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejmech.2018.10.065","article-title":"Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents","volume":"162","author":"Tejer\u00eda","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib113","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bioorg.2018.12.025","article-title":"Synthesis of novel quinoline-based thiadiazole, evaluation of their antileishmanial potential and molecular docking studies","volume":"85","author":"Almandil","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib114","doi-asserted-by":"crossref","first-page":"111860","DOI":"10.1016\/j.ejmech.2019.111860","article-title":"Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1","volume":"186","author":"Bhat","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib115","first-page":"712","article-title":"Synthesis, in silico study and antileishmanial evaluation of new selenides derived from 7-Chloro-quinoline and N-phenylacetamides","volume":"32","author":"Huang","year":"2021","journal-title":"J.\u00a0Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113606_bib116","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bioorg.2018.10.053","article-title":"Synthesis and biological evaluation of new quinoline derivatives as antileishmanial and antitrypanosomal agents","volume":"83","author":"Chanquia","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib117","series-title":"The Chemistry of Chalcones and Related Compounds","author":"Dhar","year":"1981"},{"key":"10.1016\/j.ejmech.2021.113606_bib118","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejmech.2014.08.033","article-title":"Recent developments in biological activities of chalcones: a mini review","volume":"85","author":"Singh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib119","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejmech.2019.02.028","article-title":"Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: design, synthesis and evaluation","volume":"167","author":"Espinoza-Hicks","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/biom9110643","article-title":"Evaluation of novel chalcone-thiosemicarbazones derivatives as potential anti-leishmania amazonensis agents and its HSA binding studies","volume":"9","author":"Mendes","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2021.113606_bib121","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejmech.2018.04.057","article-title":"Identification of chalcone-based antileishmanial agents targeting trypanothione reductase","volume":"152","author":"Ortalli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib122","doi-asserted-by":"crossref","first-page":"108850","DOI":"10.1016\/j.cbi.2019.108850","article-title":"Novel functionalized 1, 2, 3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis","volume":"315","author":"Meinel","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113606_bib123","doi-asserted-by":"crossref","first-page":"104122","DOI":"10.1016\/j.bioorg.2020.104122","article-title":"Synthesis, trypanocidal and anti-leishmania activity of new triazole-lapachol and nor-lapachol hybrids","volume":"103","author":"Pertino","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib124","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/jo9614708","article-title":"Efficient synthesis of aminonaphthoquinones and azidobenzohydroquinones: mechanistic considerations of the reaction of hydrazoic acid with quinones. An overview","volume":"62","author":"Couladouros","year":"1997","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib125","series-title":"Synthesis and in\u00a0Vitro Antimycobacterial and Antileishmanial Activities of Hydroquinone-Triazole Hybrids","author":"Horn","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113606_bib126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00044-018-2274-x","article-title":"Green synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1, 2, 4-triazoles","volume":"28","author":"El-Saghier","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib127","series-title":"Vitro Activity, Docking and Molecular Dynamic Simulations","article-title":"Antileishmanial effects of 4-phenyl-1-[2-(phthalimido-2-yl) ethyl]-1H-1, 2, 3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: in silico ADMET","author":"Holanda","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113606_bib128","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/j.bmcl.2017.06.053","article-title":"Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1, 2, 4-triazole-3-thiols: synthesis, biological evaluations and computational studies","volume":"27","author":"Patil","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113606_bib129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/2211352517666190527112955","article-title":"Synthesis and biological activity of some aminothiazole derivatives as antileishmanial agents","volume":"18","author":"Rezaei","year":"2020","journal-title":"Anti-Infect. Agents"},{"key":"10.1016\/j.ejmech.2021.113606_bib130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2016.01.010","article-title":"Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi","volume":"111","author":"de Moraes Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.05.005","article-title":"In\u00a0vitro evaluation of cytotoxicity and leishmanicidal activity of phthalimido-thiazole derivatives","volume":"105","author":"dos Santos Alian\u00e7a","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113606_bib132","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1016\/j.bmc.2019.07.009","article-title":"2-(Bipiperidin-1-yl)-5-(nitroaryl)-1, 3, 4-thiadiazoles: synthesis, evaluation of in\u00a0vitro leishmanicidal activity, and mechanism of action","volume":"27","author":"Mojallal-Tabatabaei","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2014.08.012","article-title":"2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation","volume":"86","author":"de Oliveira Cardoso","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgar.2020.02.028","article-title":"Study of in\u00a0vitro biological activity of thiazoles on Leishmania (Leishmania) infantum","author":"de Oliveira","year":"2020","journal-title":"J.\u00a0Glob. Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2021.113606_bib135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejmech.2018.04.003","article-title":"Anti-leishmanial click modifiable thiosemicarbazones: design, synthesis, biological evaluation and in silico studies","volume":"151","author":"Temraz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib136","doi-asserted-by":"crossref","first-page":"108899","DOI":"10.1016\/j.cbi.2019.108899","article-title":"Novel indol-3-yl-thiosemicarbazone derivatives: obtaining, evaluation of in\u00a0vitro leishmanicidal activity and ultrastructural studies","volume":"315","author":"da Silva","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113606_bib137","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molstruc.2018.11.017","article-title":"Synthesis and comparison of antileishmanial and cytotoxic activities of S-(\u2212)-limonene benzaldehyde thiosemicarbazones with their R-(+)-analogues","volume":"1179","author":"Batista","year":"2019","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2021.113606_bib138","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1007\/s11033-020-05887-5","article-title":"Investigation of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-chromen-2-one as a promising coumarin compound for the development of a new and orally effective antileishmanial agent","volume":"47","author":"de Figueiredo Peloso","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejmech.2021.113606_bib139","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00044-016-1729-1","article-title":"Synthesis and in\u00a0vitro evaluation of leishmanicidal activity of 7-hydroxy-4-phenylcoumarin derivatives","volume":"26","author":"Rosa","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib140","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.bmcl.2015.12.085","article-title":"Antileishmanial activity of novel indolyl\u2013coumarin hybrids: design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction","volume":"26","author":"Sangshetti","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113606_bib141","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1007\/s00044-019-02446-x","article-title":"Chroman-4-one hydrazones derivatives: synthesis, characterization, and in\u00a0vitro and in\u00a0vivo antileishmanial effects","volume":"28","author":"Upegui","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib142","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1039\/b201543a","article-title":"Combined microwave and ultrasound assisted Williamson ether synthesis in the absence of phase-transfer catalysts","volume":"4","author":"Peng","year":"2002","journal-title":"Green Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib143","doi-asserted-by":"crossref","first-page":"13251","DOI":"10.3390\/molecules190913251","article-title":"Synthesis, leishmanicidal and cytotoxic activity of triclosan-chalcone, triclosan-chromone and triclosan-coumarin hybrids","volume":"19","author":"Otero","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113606_bib144","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00044-017-1846-5","article-title":"Synthesis, leishmanicidal, trypanocidal and cytotoxic activities of quinoline-chalcone and quinoline-chromone hybrids","volume":"26","author":"Coa","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib145","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3390\/molecules22122041","article-title":"Synthesis and evaluation of thiochroman-4-One derivatives as potential leishmanicidal agents","volume":"22","author":"Vargas","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113606_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03614","article-title":"Synthesis and evaluation of novel chromanone and quinolinone analogues of uniflorol as anti-leishmanial agents","volume":"6","author":"Castro","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2021.113606_bib147","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0040-4020(01)92229-X","article-title":"Recent advances in the Staudinger reaction","volume":"48","author":"Gololobov","year":"1992","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113606_bib148","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.bmcl.2018.08.040","article-title":"Synthesis and biological evaluation of isoxazolyl-sulfonamides: a non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus","volume":"28","author":"da Rosa","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113606_bib149","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1021\/acs.jmedchem.0c00211","article-title":"Tellurides bearing sulfonamides as novel inhibitors of leishmanial carbonic anhydrase with potent antileishmanial activity","volume":"63","author":"Angeli","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib150","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acs.jmedchem.6b01447","article-title":"Antileishmanial activity of pyrazolopyridine derivatives and their potential as an adjunct therapy with miltefosine","volume":"60","author":"Anand","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib151","doi-asserted-by":"crossref","first-page":"102986","DOI":"10.1016\/j.bioorg.2019.102986","article-title":"Targeting malaria and leishmaniasis: synthesis and pharmacological evaluation of novel pyrazole-1, 3, 4-oxadiazole hybrids. Part II","volume":"89","author":"Verma","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib152","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2016.08.048","article-title":"Synthesis and evaluation against Leishmania amazonensis of novel pyrazolo [3, 4-d] pyridazinone-N-acylhydrazone-(bi) thiophene hybrids","volume":"124","author":"Jacomini","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib153","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4155\/fmc-2018-0058","article-title":"Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents","volume":"10","author":"Bekhit","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib154","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bmcl.2015.12.095","article-title":"Design, synthesis and biological evaluation of 1, 3, 6-trisubstituted \u03b2-carboline derivatives for cytotoxic and anti-leishmanial potential","volume":"26","author":"Lunagariya","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113606_bib155","series-title":"Synthesis and Anti-leishmanial Evaluation of 1-phenyl-2, 3, 4, 9-Tetrahydro-1h-B-Carboline Derivatives against Leishmania Infantum","author":"Murugesan","year":"2016"},{"key":"10.1016\/j.ejmech.2021.113606_bib156","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcp.2016.12.012","article-title":"Novel \u03b2-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity","volume":"129","author":"Ramu","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113606_bib157","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2018.03.022","article-title":"Design, synthesis and biological evaluation of piperazinyl-\u03b2-carbolinederivatives as anti-leishmanial agents","volume":"150","author":"Ashok","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib158","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1002\/slct.201902441","article-title":"A\u00a0versatile pre and Post Ugi modification for the synthesis of natural product inspired fused peptide-carboline scaffolds as potential anti-leishmanial agents","volume":"4","author":"Khan","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2021.113606_bib159","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2018.03.014","article-title":"Synthesis, antileishmanial activity and mechanism of action studies of novel \u03b2-carboline-1, 3, 5-triazine hybrids","volume":"150","author":"Bar\u00e9a","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-019-0617-4","article-title":"Synthesis, anti-leishmanial and molecular docking study of bis-indole derivatives","volume":"13","author":"Taha","year":"2019","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib161","doi-asserted-by":"crossref","first-page":"103787","DOI":"10.1016\/j.bioorg.2020.103787","article-title":"Synthesis of N-substituted indole derivatives as potential antimicrobial and antileishmanial agents","volume":"99","author":"Tiwari","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib162","first-page":"1492","article-title":"Synthesis and evaluation of the antifungal activity of 2-(substituted-amino)-4, 5-dialkyl-thiophene-3-carbonitrile derivatives","volume":"30","author":"Junior","year":"2011","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.ejmech.2021.113606_bib163","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2478\/v10007-012-0017-y","article-title":"Preliminary antifungal and cytotoxic evaluation of synthetic cycloalkyl [b] thiophene derivatives with PLS-DA analysis","volume":"62","author":"Souza","year":"2012","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejmech.2021.113606_bib164","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1016\/j.bmc.2016.04.057","article-title":"Antileishmanial activity of new thiophene\u2013indole hybrids: design, synthesis, biological and cytotoxic evaluation, and chemometric studies","volume":"24","author":"F\u00e9lix","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib165","doi-asserted-by":"crossref","first-page":"112146","DOI":"10.1016\/j.ejmech.2020.112146","article-title":"Synthesis and in\u00a0vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents","volume":"191","author":"Mathias","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib166","doi-asserted-by":"crossref","first-page":"111568","DOI":"10.1016\/j.ejmech.2019.111568","article-title":"Imidazo [2, 1-a] isoindole scaffold as an uncharted structure active on Leishmania donovani","volume":"182","author":"Ars\u00e8ne","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib167","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11030-018-9830-7","article-title":"Systematic search for benzimidazole compounds and derivatives with antileishmanial effects","volume":"22","author":"S\u00e1nchez-Salgado","year":"2018","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2021.113606_bib168","series-title":"Discovery of Benzimidazole-based Leishmania Mexicana Cysteine Protease CPB 2.8 \u0394 CTE Inhibitors as Potential Therapeutics for Leishmaniasis","author":"De Luca","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113606_bib169","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acsmedchemlett.8b00347","article-title":"Nongenotoxic 3-Nitroimidazo [1, 2-a] pyridines are NTR1 substrates that display potent in\u00a0vitro antileishmanial activity","volume":"10","author":"Fersing","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113606_bib170","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/1062936X.2019.1684357","article-title":"Structure based designing of benzimidazole\/benzoxazole derivatives as anti-leishmanial agents","volume":"30","author":"Kapil","year":"2019","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib171","doi-asserted-by":"crossref","first-page":"1800290","DOI":"10.1002\/ardp.201800290","article-title":"Design and synthesis of imidazolidinone derivatives as potent anti-leishmanial agents by bioisosterism","volume":"352","author":"Ramu","year":"2019","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2021.113606_bib172","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1081\/SCC-100105339","article-title":"Microwave assisted Knoevenagel condensation: a facile method for the synthesis of chalcones","volume":"31","author":"Reddy","year":"2001","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2021.113606_bib173","doi-asserted-by":"crossref","first-page":"111688","DOI":"10.1016\/j.ejmech.2019.111688","article-title":"Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis","volume":"183","author":"Rodrigues","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib174","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00044-017-2076-6","article-title":"Synthesis and antiprotozoal activity of furanchalcone\u2013quinoline, furanchalcone\u2013chromone and furanchalcone\u2013imidazole hybrids","volume":"27","author":"Garc\u00eda","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113606_bib175","doi-asserted-by":"crossref","first-page":"111742","DOI":"10.1016\/j.ejmech.2019.111742","article-title":"Biological activity, and mechanism of action of new 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, a potent and new classes of antileishmanial agents","volume":"184","author":"Coimbra","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib176","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10340-012-0466-6","article-title":"Synthesis of N-substituted dimethylmaleimides and their antifungal activities against Sclerotinia sclerotiorum","volume":"86","author":"Shen","year":"2013","journal-title":"J.\u00a0Pest. Sci."},{"key":"10.1016\/j.ejmech.2021.113606_bib177","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.bmc.2011.03.038","article-title":"Antifungal, cytotoxic and SAR studies of a series of N-alkyl, N-aryl and N-alkylphenyl-1, 4-pyrrolediones and related compounds","volume":"19","author":"Sortino","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib178","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/molecules23112878","article-title":"Anti-leishmanial and cytotoxic activities of a series of maleimides: synthesis, biological evaluation and structure-activity relationship","volume":"23","author":"Fan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113606_bib179","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1039\/D0MD00123F","article-title":"An investigation of the antileishmanial properties of semi-synthetic saponins","volume":"11","author":"Anderson","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113606_bib180","doi-asserted-by":"crossref","first-page":"95545","DOI":"10.1039\/C5RA18019H","article-title":"A\u00a0hyaluronic acid\u2013pentamidine bioconjugate as a macrophage mediated drug targeting delivery system for the treatment of leishmaniasis","volume":"5","author":"Micale","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113606_bib181","doi-asserted-by":"crossref","first-page":"30628","DOI":"10.1039\/C6RA05557E","article-title":"Targeting of the Leishmania mexicana cysteine protease CPB2. 8\u0394CTE by decorated fused benzo [b] thiophene scaffold","volume":"6","author":"Scala","year":"2016","journal-title":"RSC Adv."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:30:01Z","timestamp":1759329001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421004554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":181,"alternative-id":["S0223523421004554"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113606","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113606"}}